EUVIMEDEUVIMED entdecken
Fallbericht

Relapse of Atypical Haemolytic Uremic Syndrome After a Decade of Remission: A Case Report

Chetan Bansod, Arif Maldar

International Journal of Drug Delivery Technology · 25.05.2026 · 16 (34s)

DOI: 10.25258/ijddt.16.34s.112 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 25.05.2026. Verfasst von Chetan Bansod und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening form of thrombotic microangiopathy caused by dysregulation of the alternative complement pathway. Relapse following a prolonged remission is uncommon and poses diagnostic and therapeutic challenges, especially in resource-limited settings. Case Presentation: An 18-year-old male with a past history of hemolytic uremic syndrome treated in childhood presented with decreased urine output, nausea, and fatigue for one week. He had no recent history of diarrhea or drug exposure. On examination, he was pale and normotensive without edema. Laboratory evaluation revealed hemoglobin 5.8 g/dL, platelets 1.05 × 10⁵/μL, creatinine 6.72 mg/dL, lactate dehydrogenase 521 U/L, and reduced complement C3 (75 mg/dL). Peripheral smear showed 3–4 schistocytes per high-power field, consistent with microangiopathic hemolysis. Urinalysis revealed 3+ protein and microscopic hematuria. Ultrasound abdomen demonstrated bilateral grade II renal parenchymal changes with moderate ascites. Renal biopsy showed thrombotic microangiopathy involving glomeruli and arterioles, confirming the diagnosis of aHUS relapse. He was managed with hemodialysis, one session of plasma exchange (3 L plasma replaced with fresh frozen plasma), and high-dose corticosteroids. The patient’s hematological parameters and renal function improved gradually, and he was discharged with advice for immunosuppressive therapy and follow-up for complement-targeted treatment.

Zitieren

APA

Bansod, C., & Maldar, A. (2026). Relapse of Atypical Haemolytic Uremic Syndrome After a Decade of Remission: A Case Report. International Journal of Drug Delivery Technology, 16(34s). https://doi.org/10.25258/ijddt.16.34s.112

Vancouver

Bansod C, Maldar A. Relapse of Atypical Haemolytic Uremic Syndrome After a Decade of Remission: A Case Report. International Journal of Drug Delivery Technology. 2026;16(34s). doi:10.25258/ijddt.16.34s.112

BibTeX
@article{Bansod2026,
  author = {Bansod, Chetan and Maldar, Arif},
  title = {Relapse of Atypical Haemolytic Uremic Syndrome After a Decade of Remission: A Case Report},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {34s},
  doi = {10.25258/ijddt.16.34s.112}
}
Kostenlos starten →